Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.68 |
| ▸ | CASP3 | P42574 | 2/20 | 0.58 |
| ▸ | CASP7 | P55210 | 2/20 | 0.58 |
| ▸ | CASP6 | P55212 | 2/20 | 0.58 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.58 |
| ▸ | CASP2 | P42575 | 1/20 | 0.58 |
| ▸ | TDP2 | O95551 | 1/20 | 0.45 |
| ▸ | CASP9 | P55211 | 1/20 | 0.45 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 4/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.45 |
| ▸ | FER | P16591 | 1/20 | 0.45 |
| ▸ | LTK | P29376 | 1/20 | 0.45 |
| ▸ | CDK8 | P49336 | 1/20 | 0.45 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.45 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.45 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalimide SCHEMBL27169395 | 0.98 | GSK3B (0.65) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL698223 | 0.98 | GSK3B (0.65) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL14861040 | 0.93 | GSK3B (0.65) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL28810882 | 0.91 | GSK3B (0.75) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL28372975 | 0.85 | GSK3B (0.83) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL27772865 | 0.83 | GSK3B (0.79) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL29366030 | 0.83 | GSK3B (1.00) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL30125197 | 0.83 | GSK3B (1.00) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL11040503 | 0.83 | GSK3B (1.00) | GSK3BCASP3CASP7CASP6CASP8 | |
| Phthalimide SCHEMBL10192661 | 0.83 | GSK3B (1.00) | GSK3BCASP3CASP7CASP6CASP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4268651-A1 | FIBER-TREATING AGENT | Kao Corporation (JP) | 2023-11-01 | — | — | EP | claimed |
| EP-4268653-A1 | FIBER-TREATING AGENT | Kao Corporation (JP) | 2023-11-01 | — | — | EP | claimed |
| EP-4268652-A1 | FIBER TREATMENT AGENT | Kao Corporation (JP) | 2023-11-01 | — | — | EP | claimed |
| EP-4268650-A1 | FIBER TREATMENT AGENT | Kao Corporation (JP) | 2023-11-01 | — | — | EP | claimed |
| CN-116783347-A | Fiber treatment agent | 花王株式会社 | 2023-09-19 | — | — | CN | claimed |
| CN-116745484-A | fiber treatment agent | 花王株式会社 | 2023-09-12 | — | — | CN | claimed |
| CN-116710610-A | Fiber treatment agent | 花王株式会社 | 2023-09-05 | — | — | CN | claimed |
| CN-116648538-A | Fiber treatment agent | 花王株式会社 | 2023-08-25 | — | — | CN | claimed |
| US-20230087728-A1 | FIBER TREATMENT AGENT COMPOSITION | KAO CORPORATION (JP) | 2023-03-23 | — | — | US | claimed |
| EP-4018864-A1 | HUMAN HAIR FIBER TREATMENT AGENT | Kao Corporation (JP) | 2022-06-29 | — | — | EP | claimed |
| CN-114080213-A | Hair treatment method | 花王株式会社 | 2022-02-22 | — | — | CN | claimed |
| US-20140235885-A1 | COPOLYMERS OF EPOXY COMPOUNDS AND AMINO SILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2014-08-21 | — | — | US | claimed |
| US-11951198-B2 | Method and kit for processing hair | LIW PATENT COMPANY LIMITED BY GUARANTEE (IE) | 2024-04-09 | — | — | US | disclosed |
| US-20240068156-A1 | FIBER-TREATING AGENT | KAO CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240058249-A1 | FIBER-TREATING AGENT | KAO CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| US-20240060234-A1 | FIBER-TREATING AGENT | KAO CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| WO-2009061371-A2 | COPOLYMERS OF EPOXY COMPOUNDS AND AMINO SILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| WO-2009061360-A1 | PERSONAL CARE COMPOSITION COMPRISING A REACTION PRODUCT OF EPOXY COMPOUND AND AMINO SILANE | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090118421-A1 | COPOLYMER OF EPOXY COMPOUNDS AND AMINO SILANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-05-07 | — | — | US | disclosed |
| US-20090117793-A1 | Textiles treated with copolymers of epoxy compounds and amino silanes having enhanced wet-strength | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235885-A1 | COPOLYMERS OF EPOXY COMPOUNDS AND AMINO SILANES | OXGR1, SRM, OXER1 | GSK3B 4762/4885CASP3 3002/4885CASP7 4606/4885 |
| US-11951198-B2 | Method and kit for processing hair | KRT18, PHB1, BTD | GSK3B 2260/4885CASP3 998/4885CASP7 256/4885 |
| US-20230087728-A1 | FIBER TREATMENT AGENT COMPOSITION | SMARCA1, SMARCA2, COL1A1 | GSK3B 4111/4885CASP3 2435/4885CASP7 1814/4885 |
| US-20240058249-A1 | FIBER-TREATING AGENT | H1-5, FAU, H1-3 | GSK3B 3886/4885CASP3 615/4885CASP7 768/4885 |
| US-20240068156-A1 | FIBER-TREATING AGENT | H1-5, H1-3, H1-4 | GSK3B 3824/4885CASP3 1000/4885CASP7 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.